Notably, LCPUFAs foremost target Th1 cells [39]–[42], which are activated by microbial exposure [43], while Th2 cells, that are central in IgE-mediated allergy, are not suppressed by either n-3 or n-6 PUFAs to the same extent [12]. This evidence concerns the gene IGHE and allergic disease.